BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Paoluzi OA, Del Vecchio Blanco G, Visconti E, Coppola M, Fontana C, Favaro M, Pallone F. Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy. World J Gastroenterol 2015; 21(21): 6698-6705 [PMID: 26074708 DOI: 10.3748/wjg.v21.i21.6698]
URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6698.htm
Number Citing Articles
1
Hidekazu Suzuki, Hideki Mori. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treatJournal of Gastroenterology 2018; 53(3): 354 doi: 10.1007/s00535-017-1407-1
2
Huo-Ye Gan, Tie-Li Peng, You-Ming Huang, Kai-Hua Su, Lin-Li Zhao, Li-Ya Yao, Rong-Jiao Yang. Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trialScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27482-2
3
Eskandar Hajiani, Pezhman Alavinejad, Nahid Avandi, Abdol Rahim Masjedizadeh, Ali Akbar Shayesteh. Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical TrialMiddle East Journal of Digestive Diseases 2018; 10(4): 242 doi: 10.15171/mejdd.2018.117
4
Hideki Mori, Hidekazu Suzuki. Update on quinolone-containing rescue therapies for <i>Helicobacter pylori</i> infectionWorld Journal of Gastroenterology 2020; 26(15): 1733-1744 doi: 10.3748/wjg.v26.i15.1733
5
Siya Kong, Han Chen, Keting Huang, Duochen Jin, Guoxin Zhang, Feng Ye. Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infectionMedicine 2021; 100(10): e24915 doi: 10.1097/MD.0000000000024915
6
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016Helicobacter 2016; 21: 55 doi: 10.1111/hel.12342
7
Doxycycline/esomeprazole/levofloxacinReactions Weekly 2016; 1601(1): 112 doi: 10.1007/s40278-016-17414-8
8
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
9
Tommaso Cai, Luca Gallelli, Erika Cione, Gianpaolo Perletti, Francesco Ciarleglio, Gianni Malossini, Giovanni De Pretis, Alessandro Palmieri, Vincenzo Mirone, Riccardo Bartoletti, Truls E. Bjerklund Johansen. The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV studyWorld Journal of Urology 2021; 39(9): 3433 doi: 10.1007/s00345-020-03580-7
10
Alba A. Trespalacios-Rangél, William Otero, Azucena Arévalo-Galvis, Raúl A. Poutou-Piñales, Emiko Rimbara, David Y. Graham, Massimiliano Galdiero. Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014)PLOS ONE 2016; 11(7): e0160007 doi: 10.1371/journal.pone.0160007
11
Lei Gu, Shenglan Li, Ying He, Yi Chen, Yanzhi Jiang, Yu Peng, Xiaowei Liu, Huixiang Yang. Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study Helicobacter 2019; : e12594 doi: 10.1111/hel.12594